Farhad Pazan

1.5k total citations · 1 hit paper
18 papers, 614 citations indexed

About

Farhad Pazan is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Farhad Pazan has authored 18 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Geriatrics and Gerontology, 11 papers in Economics and Econometrics and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Farhad Pazan's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Medication Adherence and Compliance (5 papers). Farhad Pazan is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Medication Adherence and Compliance (5 papers). Farhad Pazan collaborates with scholars based in Germany, United Kingdom and Italy. Farhad Pazan's co-authors include Martin Wehling, Christel Weiß, Helmut Frohnhofen, Heinrich Burkhardt, Mobarak Abu Mraheil, Yair Aharonowitz, Torsten Hain, Trinad Chakraborty, André Billion and Benjamin Izar and has published in prestigious journals such as PLoS ONE, Age and Ageing and European Journal of Clinical Pharmacology.

In The Last Decade

Farhad Pazan

18 papers receiving 584 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences

2021 230 citations Farhad Pazan, Martin Wehling European Geriatric Medicine profile →

Peers

Countries citing papers authored by Farhad Pazan

Since Specialization

Citations

This map shows the geographic impact of Farhad Pazan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhad Pazan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhad Pazan more than expected).

Fields of papers citing papers by Farhad Pazan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhad Pazan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhad Pazan. The network helps show where Farhad Pazan may publish in the future.

Co-authorship network of co-authors of Farhad Pazan

This figure shows the co-authorship network connecting the top 25 collaborators of Farhad Pazan. A scholar is included among the top collaborators of Farhad Pazan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhad Pazan. Farhad Pazan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Validation of MyFORTA: An Automated Tool to Improve Medications in Older People Based on the FORTA List 2024 ·Drugs & Aging ·Martin Wehling, (unknown), Christel Weiß, Kathrin Heser, Alexander Pabst, Melanie Luppa, Horst Bickel, Siegfried Weyerer, Michael Pentzek, Hans‐Helmut König, Dagmar Lühmann, Carolin van der Leeden, Martin Scherer, Steffi G. Riedel‐Heller, Michael Wagner, Farhad Pazan	1
2	Medication optimization according to the Fit fOR The Aged (FORTA) rules improves functional status in patients hospitalized for geriatric rehabilitation 2023 ·European Geriatric Medicine ·Farhad Pazan, Martin Wehling, Christel Weiß, Helmut Frohnhofen	2
3	Die FORTA (Fit fOR The Aged) Liste 2023 ·Die Innere Medizin ·Farhad Pazan, Martin Wehling	1
4	Higher FORTA (Fit fOR The Aged) scores are associated with poor functional outcomes, dementia, and mortality in older people 2022 ·European Journal of Clinical Pharmacology ·Farhad Pazan, Hanna Breunig, Christel Weiß, Susanne Röhr, Melanie Luppa, Michael Pentzek, Horst Bickel, Dagmar Weeg, Siegfried Weyerer, Birgitt Wiese, Hans‐Helmut König, Christian Brettschneider, Kathrin Heser, Wolfgang Maier, Martin Scherer, Steffi G. Riedel‐Heller, Michael Wagner, Martin Wehling	2
5	The Sex-Specific Impact of the FORTA (Fit-fOR-The-Aged) List on Medication Quality and Clinical Endpoints in Older Hospitalized Patients: Secondary Analysis of a Randomized Controlled Trial 2022 ·Drugs - Real World Outcomes ·(unknown), Christel Weiß, Heinrich Burkhardt, Helmut Frohnhofen, Martin Wehling, Farhad Pazan	1
6	International Validation of the Turkish Inappropriate Medication Use in the Elderly (TIME) Criteria Set: A Delphi Panel Study 2021 ·Drugs & Aging ·Gülistan Bahat, Birkan İlhan, Tuğba Erdoğan, Meryem Merve Ören, Mehmet Akif Karan, Heinrich Burkhardt, Michael Denkinger, Doron Garfinkel, Alfonso J. Cruz‐Jentoft, (unknown), Graziano Onder, Farhad Pazan, Eline Tommelein, Eva Topinková, Nathalie van der Velde, Mirko Petrović	20
7	Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences breakdown → 2021 ·European Geriatric Medicine ·Farhad Pazan, Martin Wehling	230
8	A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019) 2020 ·Drugs & Aging ·Farhad Pazan, Rónán Collins, Víctor Gil, Olivier Hanon, Roland Hardt, (unknown), Pedro Monteiro, Terence J. Quinn, Dieter Ropers, Giuseppe Sergi, Freek W.A. Verheugt, Martin Wehling	4
9	The JAPAN-FORTA (Fit fOR The Aged) list: Consensus validation of a clinical tool to improve drug therapy in older adults 2020 ·Archives of Gerontology and Geriatrics ·Farhad Pazan, (unknown), Christel Weiß, Martin Wehling, Hiroshi Akazawa, Taro Kojima, (unknown), Masahiro Akishita, Yasushi Takeya, Yoshiyuki Ohno, Takashi Yamanaka, Koichi Kozaki, Yusuke Suzuki, Katsuyoshi Mizukami, Fumihiro Mizokami, Yoshiyuki Ikeda, Atsuya Shimizu	14
10	The Fit fOR The Aged (FORTA) project and its clinical implications 2020 ·Expert Opinion on Drug Metabolism & Toxicology ·Farhad Pazan, Martin Wehling	2
11	The U.S.-FORTA (Fit fOR The Aged) List: Consensus Validation of a Clinical Tool to Improve Drug Therapy in Older Adults 2019 ·Journal of the American Medical Directors Association ·Farhad Pazan, (unknown), Christel Weiß, Martin Wehling, Zachary A. Marcum, (unknown), (unknown), (unknown), (unknown), Shelly L. Gray, (unknown), (unknown)	31
12	A systematic review and novel classification of listing tools to improve medication in older people 2019 ·European Journal of Clinical Pharmacology ·Farhad Pazan, (unknown), Martin Wehling	40
13	The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People 2018 ·Drugs & Aging ·(unknown), Farhad Pazan, Christel Weiß, Martin Wehling	68
14	Higher Fit-fOR-The-Aged (FORTA) Scores Comprising Medication Errors are Associated with Impaired Cognitive and Physical Function Tests in the VALFORTA Trial 2018 ·Drugs & Aging ·Farhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, Christel Weiß, (unknown), (unknown), Martin Wehling	7
15	Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatments 2017 ·European Journal of Clinical Pharmacology ·Farhad Pazan, Heinrich Burkhardt, Helmut Frohnhofen, Christel Weiß, (unknown), (unknown), Martin Wehling	16
16	VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification 2016 ·Age and Ageing ·Martin Wehling, Heinrich Burkhardt, (unknown), Farhad Pazan, (unknown), Christel Weiß, Helmut Frohnhofen	101
17	P-426: Clinical validation of the FORTA (Fit fOR The Aged) List in a prospective randomized controlled clinical study 2015 ·European Geriatric Medicine ·Martin Wehling, (unknown), (unknown), Heinrich Burkhardt, Helmut Frohnhofen, Farhad Pazan, (unknown)	1
18	Universal Stress Proteins Are Important for Oxidative and Acid Stress Resistance and Growth of Listeria monocytogenes EGD-e In Vitro and In Vivo 2011 ·PLoS ONE ·(unknown), Benjamin Izar, Farhad Pazan, Walid Mohamed, Mobarak Abu Mraheil, Krishnendu Mukherjee, André Billion, Yair Aharonowitz, Trinad Chakraborty, Torsten Hain	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact